The pharmaceutical companies on Thursday assured the Wafaqi Mohtasib of their full cooperation in the production of life saving drugs at affordable prices, that are currently unavailable in the market.
This assurance was given by the drug manufacturing and producing companies during a meeting held here at the Wafaqi Mohtasib Secretariat chaired by Wafaqi Mohtasib M. Salman Faruqui.
The Wafaqi Mohtasib appreciated the efforts of the government and the manufacturers which are being made to resolve the issue of availability of essential drugs at affordable price. He stated that Wafaqi Mohtasib Secretariat had taken cognizance of the non-availability of essential drugs in the country and had constituted a committee comprising eminent doctors, pharmacists, drug manufacturers and other stake holders.
The Chairman of the committee Prof. Emeritus Lt. Gen (Retd) Mahmood Ahmad Akhtar, Former Surgeon General, Pakistan Army gave a detailed briefing on the situation caused due to non-availability of essential drugs. He was of the view that this happened due to inaction on the part of stake holders for implementing the essential drugs scheme adopted by developing and under developed nations in the world. He emphasized that implementation of Essential Drugs Scheme would minimize the fatalities due to iatrogenic diseases by removing irrational and harmful drugs from the market. He suggested that by making primary antibiotic available the problem of bacterial resistance which has caused crisis progression would also be tackled.
Wafaqi Mohtasib M. Salman Faruqui was apprised by the convenors of the sub-committee on the recommendations made to ensure the availability of essential drugs at affordable prices.
Earlier, Jaweed Akhter, Senior Advisor, Wafaqi Mohtasib Secretariat and Secretary of the Committee gave a detailed presentation on Essential Drugs Scheme covering issues relating to availability of essential drugs having high standards in terms of quality, safety and efficacy at affordable prices and Pakistan Pharma Market and the progress made to-date.
The convenors of sub-committee comprising eminent professionals submitted their recommendations for ensuring availability of essential drugs having high standards in terms of efficacy, safety, and quality at affordable prices.